Chemical Biology and Drug Design

JANUARY 1, 2024

Herbal medicine has become a safe, non-toxic and easily available source of cancer-treating compounds. Chinese motherwort (YiMuCao, Leonurus japonicus ) is a traditional Chinese herb showing beneficial effects for obstetrical and gynecological diseases. Among the active compounds, Stachydrine has been widely investigated, which makes us wonder whether Stachydrine can also exert its tumor-suppressive effects on BC.

Bioinformatics 100

Bioinformatics Regulations Disease Research 100

Drugs.com

JANUARY 1, 2024

MONDAY, Jan. 1, 2024 -- Still weighing whether to make a New Year’s resolution? Or perhaps regretting letting your healthy habits slide during the holidays?Either way, the American Medical Association (AMA) has ten recommendations to help.

Doctors 105

Doctors 105

Drug Patent Watch

JANUARY 1, 2024

This chart shows the pharmaceutical companies with the most patents in Ireland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical companies have the most drug patents in Ireland? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 90

Pharmaceutical Companies Pharmaceuticals Drugs 90

FDA Law Blog: Biosimilars

JANUARY 1, 2024

By Douglas B. Farquhar & Aisha T. Evans* & Irene Namata* — Primacy and recency are recognized psychological phenomena: people tend to remember the first thing they hear, and the last. It’s why litigators concentrate on their opening statement to a jury, and their closing argument. Maybe that’s also why FDA last week publicized the highest number of important Warning Letters of the year (compared with prior releases in 2023).

FDA 57

FDA Clinical Trials FDA Compliance Production 57

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Treatment

Common Sense for Drug Policy Blog

JANUARY 1, 2024

Determining Whether a Syringe Services Program Saves Money "Methods "The research literature on the effectiveness of syringe services programs in controlling HIV transmission among persons who inject drugs and guidelines for syringe services program that are “functioning very well” were used to estimate the cost-saving threshold at which a syringe services program becomes cost-saving through preventing HIV infections versus lifetime treatment of HIV.

Treatment 52

Treatment Drugs Research 52

Common Sense for Drug Policy Blog

JANUARY 1, 2024

Spending on Needle and Syringe Service Programs Globally "Our systematic review identified 55 NSP unit cost estimates from 14 middle and high-income countries. Higher unit costs were associated with countries with higher HSRI and fewer syringes distributed, and with newer programs, which confirmed our hypothesis. The number of intervention components included was not seen to affect the unit cost, possibly because the majority of programs did not include any additional WHO-recommended interventio

40

40

Common Sense for Drug Policy Blog

JANUARY 1, 2024

Cost-Effectiveness of Syringe Service Programs and Medications for Opioid Use Disorder "This study indicates that the SSP+MOUD [Syringe Service Program + Medications for Opioid Use Disorder] combination program is an effective harm-reduction strategy to prevent HCV cases among opioid IDUs and is cost-effective if payers are willing to pay $4,699 or more per avoided case of HCV.

Disease 40

Disease Drugs 40

Common Sense for Drug Policy Blog

JANUARY 1, 2024

Cost Savings From Preventing HIV Infection "Effective treatment has increased life expectancy after HIV infection, and deaths from non-AIDS-related causes now exceed deaths from AIDS for those with HIV in the US [ 35 ]. Medical costs of treating HIV-infected individuals as they age now include costs of both HIV-related and HIV-unrelated medical care.

Treatment 40

Treatment Drugs 40

Common Sense for Drug Policy Blog

JANUARY 1, 2024

Cost Savings From Syringe Service Programs in Baltimore, MD and Philadelphia, PA Editor's Note: This article has the following correction: "In the December 1, 2019 Supplement 2 of JAIDS Journal of Acquired Immune Deficiency Syndromes , in the article titled “Using Interrupted Time Series Analysis to Measure the Impact of Legalized Syringe Exchange on HIV Diagnoses in Baltimore and Philadelphia”, the authors mistakenly reported the estimated cost savings for Baltimore to be $62.4 million annually

Treatment 40

Treatment Government Regulations Disease 40